CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Commercial Officer sold 651 shares at $8.08 ($5,260)
- 4 Exercise or conversion General Counsel acquired 2,344 shares (option exercise)
- 4 Planned sale Chief Operations Officer sold 597 shares at $8.08 ($4,824)
- 4 Exercise or conversion Chief Financial Officer acquired 2,344 shares (option exercise)
- 4/A Open-market sale Chief Commercial Officer sold 2,171 shares at $7.56 ($16,405)
- 4/A Grant or award Chief Commercial Officer acquired 2,160 shares (grant or award)
- 4/A Grant or award Chief Executive Officer acquired 993 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 1,927 shares (grant or award)
- 4/A Grant or award Chief Operations Officer acquired 1,918 shares (grant or award)
- 4/A Grant or award General Counsel acquired 2,166 shares (grant or award)
- 4 Open-market sale Chief Operations Officer sold 2,033 shares at $7.56 ($15,362)
- 4 Exercise or conversion Chief Financial Officer acquired 9,375 shares (option exercise)
- 4 Open-market sale Chief Commercial Officer sold 2,171 shares at $7.56 ($16,405)
- 4 Exercise or conversion General Counsel acquired 9,375 shares (option exercise)
- 4 Grant or award Chief Operations Officer acquired 83,333 shares (grant or award)
Page 15 of 21 · 414 filings